GSK announces largest private financial contribution to CIHR's Team Grants initiative addressing threats to Canadian lung health
GSK is investing $2 million in research to address ongoing, new, and emerging threats to lung health in Canada. The funds will be managed and administered by the Canadian Institutes of Health Research (CIHR) through the Team Grants in Lung Health initiative. GSK's contribution is the largest private financial contribution to this research initiative to date.
Source: yahoo.com
